☆ 4.7 Article

Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection

FRONTIERS IN PUBLIC HEALTH (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

Luca M. Zaeck et al.

Summary: In July 2022, the monkeypox outbreak was declared an international public health emergency. Historic smallpox vaccination and monkeypox virus infection can generate MPXV-neutralizing antibodies, but vaccination with MVA-BN results in lower levels of these antibodies. Further studies are needed to assess the efficacy of the MVA-BN vaccine in at-risk populations.

NATURE MEDICINE (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

Agam K. Rao et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Review Immunology

Poxviruses and the immune system: Implications for monkeypox virus

Amene Saghazadeh et al.

Summary: Poxviruses (PXVs) are viruses that cause smallpox and pox-like infections. In recent decades, PXV outbreaks have occurred in both endemic and non-endemic areas. The cessation of smallpox vaccination is believed to be a major reason for the changing epidemiology of PXV infections. The immune system recognizes PXVs and elicits responses, but PXVs can evade these responses. Discussions on PXV immunization are more prevalent than those on PXV infection.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Add to Collection

Review Environmental Sciences

Monkeypox: A Mini-Review on the Globally Emerging Orthopoxvirus

Amy Evans et al.

Summary: This mini review analyzed the literature on monkeypox published from 2017 onward and provided epidemiological context for current outbreaks. Epidemiological studies suggest an increase in the age of onset of monkeypox. Antivirals are recommended for the management of confirmed cases, while preventive measures can include the use of smallpox vaccine.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Add to Collection

Article Immunology

The 2022 outbreak and the pathobiology of the monkeypox virus

Narendra Kumar et al.

Summary: Two cases of monkeypox virus infection in individuals returning from Nigeria to the USA have led to a dramatic increase in infection rates. As of June 10, 2022, over 1,500 cases have been reported in 43 countries, including Europe and North America. While monkeypox virus is prevalent in central and western Africa, its presence in developed countries has raised concerns about global spread.

JOURNAL OF AUTOIMMUNITY (2022)

Add to Collection

Editorial Material Medicine, General & Internal

Monkeypox as a PHEIC: implications for global health governance

Clare Wenham et al.

LANCET (2022)

Add to Collection

Article Virology

Effect of Monkeypox Virus Preparation on the Lethality of the Intravenous Cynomolgus Macaque Model

Eric M. Mucker et al.

Summary: Researchers have been working for over two decades to improve smallpox vaccines and develop therapies for smallpox or similar diseases. The use of animal models, such as macaques infected with monkeypox virus, has been crucial in advancing these therapies. However, there have been criticisms regarding the administration method and dosage used in these models.

VIRUSES-BASEL (2022)

Add to Collection

Review Immunology

Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters

Yan Xiang et al.

Summary: Monkeypox virus is a closely related virus to smallpox virus, causing a milder febrile rash illness in humans. While it used to be a rare zoonotic disease confined to forested areas in West and Central Africa, the number of cases and geographical range have significantly increased in recent years. The outbreak of monkeypox since May 2022 in multiple countries, with a large number of cases and no direct links to endemic areas, raises concerns about a possible change in transmission pattern and a greater global threat. This review highlights recent progress in understanding the virus host range, evolutionary potential, and neutralization targets for risk assessment and preparedness for a monkeypox epidemic.

EMERGING MICROBES & INFECTIONS (2022)

Add to Collection

Article Infectious Diseases

Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study

Ana Atti et al.

Summary: This study investigated the serological differences between SARS-CoV-2 reinfection cases and controls, and identified antibody correlates of protection against reinfection. The results showed that before vaccination, protection against reinfection was directly correlated with anti-S levels, PV-N and LV-N titres, but not with anti-N levels.

JOURNAL OF INFECTION (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Kinetic and Structural Aspects of Glycosaminoglycan-Monkeypox Virus Protein A29 Interactions Using Surface Plasmon Resonance

Deling Shi et al.

Summary: Monkeypox virus (MPXV) is spreading globally, with an increase in cases through intimate personal contact, particularly in the United States. This study shows that the MPXV A29 protein binds to GAGs, including heparin and chondroitin sulfate/dermatan sulfate, and the negative charges on GAGs are crucial for this interaction. GAG analogs, such as pentosan polysulfate and mucopolysaccharide polysulfate, can effectively inhibit the binding of MPXV A29 to heparin.

MOLECULES (2022)

Add to Collection

Article Virology

Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox Virus

Syed Faraz Ahmed et al.

Summary: In May 2022, a novel cluster of monkeypox virus infections in humans was detected, causing global concern. Vaccines based on the vaccinia virus have been highly effective against monkeypox viruses in the past, but the current outbreak involves genetic variations that may impact vaccine-induced immune recognition. However, research suggests that VACV-based vaccines, including MVA-BN and ACAM2000, are still highly cross-reactive against the newly observed monkeypox viruses.

VIRUSES-BASEL (2022)

Add to Collection

Article Biochemical Research Methods

The theory and practice of the viral dose in neutralization assay: Insights on SARS-CoV-2 doublethink effect

Alessandro Manenti et al.

Summary: This study aimed to compare the effects of different SARS-CoV-2 infective doses on neutralization assay results. The lower infective dose of the assay yielded higher results, indicating its potential for more accurate detection of neutralizing antibodies present in samples.

JOURNAL OF VIROLOGICAL METHODS (2021)

Add to Collection

Article Biochemical Research Methods

Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples

Livia Mazzini et al.

Summary: This study aimed to detect SARS-CoV-2-specific antibodies in human serum samples to predict population immunity, identify potential infectious individuals, and confirm the significant neutralizing effect of antibodies against the receptor-binding domain of the virus spike protein.

JOURNAL OF IMMUNOLOGICAL METHODS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Add to Collection

Article Virology

Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples

Alessandro Manenti et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Article Immunology

Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018

Aisling Vaughan et al.

EMERGING INFECTIOUS DISEASES (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Emergence of Monkeypox - West and Central Africa, 1970-2017

Kara N. Durski et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)

Add to Collection

Review Public, Environmental & Occupational Health

Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans

Nikola Sklenovska et al.

FRONTIERS IN PUBLIC HEALTH (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections

Iuliia Gilchuk et al.

CELL (2016)

Add to Collection

Article Virology

A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27

Laura J. Hughes et al.

VIROLOGY (2014)

Add to Collection

Article Cell Biology

Poxvirus DNA Replication

Bernard Moss

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)

Add to Collection

Article Immunology

Status of human monkeypox: clinical disease, epidemiology and research

Inger K. Damon

VACCINE (2011)

Add to Collection

Editorial Material Immunology

Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: Meeting at the Crossroads

Dace V. Madore et al.

VACCINE (2010)

Add to Collection

Review Virology

Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement

Mohammed Rafii-El-Idrissi Benhnia et al.

JOURNAL OF VIROLOGY (2009)

Add to Collection

Article Immunology

Monkeypox transmission and pathogenesis in prairie dogs

J Guarner et al.

EMERGING INFECTIOUS DISEASES (2004)

Add to Collection

Article Medicine, General & Internal

The detection of monkeypox in humans in the Western Hemisphere

KD Reed et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Add to Collection

Article Virology

Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement

S Lustig et al.

VIROLOGY (2004)

Add to Collection

Article Biochemistry & Molecular Biology

Duration of antiviral immunity after smallpox vaccination

E Hammarlund et al.

NATURE MEDICINE (2003)

Add to Collection

Article Virology

Antibody neutralization of the extracellular enveloped form of vaccinia virus

M Law et al.

VIROLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.